Clinical Trial Update: Synthetic Angiotensin II/Giapreza in Pediatric Patients With Refractory Hypotension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating synthetic angiotensin II (Giapreza) in pediatric patients with refractory hypotension (vasodilatory shock); enrollment is by i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vasodilatory Shock

Drugs mentioned

• Giapreza (Angiotensin II)

Snippet

Sponsor: Todd Sweberg | Conditions: Vasodilatory Shock | Phase 4 | Status: ENROLLING_BY_INVITATION